Guidelines
Cardio-Oncology guidelines
Our mission is to promote research, best clinical practice and a wider understanding of the effects of cancer treatment on the cardiovascular system.
The British Cardio-Oncology Society was formed in 2012 by UK cardiologists and oncologists from multiple sub-specialties working on the cardiovascular effects of cancer treatment. We work with local, national and international partners to improve patient care and welcome enquiries from cardiologists, oncologists, charities, the NHS and industry.
The society is an associated professional group of the British Cardiovascular Society (www.BCS.com) and worked with the International CardiOncology Society of North America to host the Global Cardio-Oncology Summit in London.
- European Society of Cardiology Guidelines on Cardio-Oncology 2022
-
Published at ESC Congress 26 August 2022
ESC Guidelines on Cardio-Oncology 2022.
"This is the first European Society of Cardiology (ESC) guideline on cardio-oncology. The aim of this guideline is to help all the healthcare professionals providing care to oncology patients before, during, and after their cancer treatments with respect to their cardiovascular health and wellness. This guideline provides guidance on the definitions, diagnosis, treatment, and prevention of cancer therapy-related CV toxicity, and the management of CV disease caused directly or indirectly by cancer. This area of medicine has limited trials and evidence to base decision making and, where evidence is limited, this guideline provides the consensus of expert opinion to guide healthcare professionals." - Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab: A Practical Guideline from the British Society of Echocardiography and the British Cardio-Oncology Society. 2021
- PJACC CardioOnc. 2021;1:1–16
- Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. 2021
- European Journal of Cancer 2021;156:127-137a>
- American Heart Association 2019
-
Cardio-Oncology: Vascular and Metabolic Perspectives
Circulation. 2019;139:e579–e602. DOI: 10.1161/CIR.0000000000000641 - European Society of Cardiology 2019
-
Diagnosis and treatment of left ventricular dysfunction and heart failure in cancer patients
E-Journal of Cardiology Practice - Vol. 16, N° 40 - 27 Feb 2019 - European Society of Cardiology 2019
-
What is the best imaging tool in cardio-oncology?
E-Journal of Cardiology Practice - Vol. 16, N° 39 - 20 Feb 2019
Contact BC-OS
E-mail